Usana Health Sciences Inc
Company Profile
Business description
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
Contact
3838 West Parkway Boulevard
Salt Lake CityUT84120
USAT: +1 801 954-7100
Sector
Consumer Defensive
Stock type
Defensive
Industry
Packaged Foods
Fiscal Year End
31 December 2026
Employees
1,570
Stocks News & Analysis
stocks
ASX healthcare share remains undervalued ahead of earnings
stocks
Alphabet earnings: Strong AI monetization continues to spearhead results
stocks
AMD: We’re pleased with Anthropic Partnership ahead of advancing AI event
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,963.40 | 10.80 | -0.12% |
| CAC 40 | 8,299.09 | 138.80 | -1.64% |
| DAX 40 | 24,763.12 | 392.29 | -1.56% |
| Dow JONES (US) | 51,711.65 | 506.93 | -0.97% |
| FTSE 100 | 10,639.17 | 77.80 | -0.73% |
| HKSE | 24,873.51 | 337.30 | -1.34% |
| NASDAQ | 25,137.69 | 553.21 | -2.15% |
| Nikkei 225 | 64,396.59 | 2,026.01 | -3.05% |
| NZX 50 Index | 13,757.51 | 37.80 | -0.27% |
| S&P 500 | 7,408.30 | 90.66 | -1.21% |
| S&P/ASX 200 | 8,793.00 | 2.70 | -0.03% |
| SSE Composite Index | 3,849.76 | 27.01 | -0.70% |